Jump Financial, LLC Zymeworks Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$4.82 - $7.7 $53,752 - $85,870	11,152 Added 25.15%	55,500 $294,000
Q1 2022 May 12, 2022	BUY	$6.0 - $16.98 $266,088 - $753,029	44,348 New	44,348 $290,000
Q4 2021 Feb 10, 2022	SELL	$15.19 - $29.33 $514,044 - $992,556	-33,841 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $925,551 - $1.26 Million	33,841 New	33,841 $983,000
Q2 2021 Aug 13, 2021	SELL	$26.5 - $38.23 $507,263 - $731,798	-19,142 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $571,005 - $1.09 Million	19,142 New	19,142 $604,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.